Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma

Clinical Endocrinology

Volumn 71, Issue 2, 2009, Pages 291-297

  Verburg, Frederik A ^a   Mäder, Uwe ^a   Luster, Markus ^a   Reiners, Christoph ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER RISK; CANCER STAGING; FEMALE; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID CARCINOMA; THYROIDECTOMY; TUMOR VOLUME;

ADULT; CARCINOMA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC PROCESSES; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; TUMOR BURDEN;

EID: 67650321016     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03482.x     Document Type: Article

References (21)

1. Mazzaferri, E.L. Jhiang, S.M. (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine, 97, 418 428. (Pubitemid 24345593)
2. Hundahl, S.A., Cady, B., Cunningham, M.P. et al. (2000) Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer, 89, 202 217. (Pubitemid 30451292)
3. Schlumberger, M. Pacini, F. (2006) Thyroid Tumors. Nucleon, Paris.
4. Cady, B. Rossi, R. (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery, 104, 947 953. (Pubitemid 19011971)
5. Hay, I.D., Grant, C.S., Taylor, W.F. et al. (1987) Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery, 102, 1088 1095. (Pubitemid 18010757)
6. Shaha, A.R., Loree, T.R. Shah, J.P. (1994) Intermediate-risk group for differentiated carcinoma of thyroid. Surgery, 116, 1036 1040.
7. Machens, A., Holzhusen, H.J. Dralle, H. (2005) The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. A comparative analysis. Cancer, 103, 2269 2273. (Pubitemid 40686570)
8. Sobin, L.H. Wittekind, C. eds (2002) TNM Classification of Malignant Tumours, 6th edn. Wiley-Liss, New York.
9. Sobin, L.H. Wittekind, C. eds (1997) TNM Classification of Malignant Tumours, 5th edn. Springer, Berlin, Heidelberg, New York, Tokyo.
10. Kaplan, E.L. Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 481.
11. Passler, C., Scheuba, C., Asari, R. et al. (2005) Importance of tumour size in papillary and follicular thyroid cancer. British Journal of Surgery, 92, 184 189. (Pubitemid 40269332)
12. Pacini, F., Schlumberger, M., Dralle, H. et al. (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology, 154, 787 803. (Pubitemid 43997716)
13. Cooper, D.S., Doherty, G.M., Haugen, B.R. et al. (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 16, 109 142.
14. Hay, I.D., Bergstralh, E.J., Goellner, J.R. et al. (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery, 114, 1050 1057.
15. Nikiforova, M.N., Kimura, E.T., Gandhi, M. et al. (2003) BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. Journal of Clinical Endocrinology and Metabolism, 88, 5399 5404. (Pubitemid 37452745)
16. Kim, J., Giuliano, A., Turner, R.R. et al. (2006) Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma. Annals of Surgery, 244, 799 804. (Pubitemid 44629955)
17. Lupi, C., Giannini, R., Ugolini, C. et al. (2007) Association of BRAF V600E mutation with poor clinicopathological outcome in 500 consecutive cases of papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 92, 4085 4090. (Pubitemid 350074715)
18. Rodolico, V., Cabibi, D., Pizzolanti, G. et al. (2007) BRAFV600E mutation and p27kip1 expression in papillary carcinomas of the thyroid <1 cm and their paired lymph node metastases. Cancer, 110, 1218 1226. (Pubitemid 47435591)
19. Frasca, F., Nucera, C., Pellegriti, G. et al. (2008) BRAF (V600E) mutation and the biology of papillary thyroid cancer. Endocrine-Related Cancer, 15, 191 205.
20. Nikiforova, M.N., Lynch, R.A., Biddinger, P.W. et al. (2003) RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. Journal of Clinical Endocrinology and Metabolism, 88, 2318 2326. (Pubitemid 36549913)
21. Lupoli, C., Vitale, G., Caraglia, M. et al. (1999) Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet, 353, 637 639. (Pubitemid 29087985)